The TNF family member 4-1BBL sustains inflammation by interacting with TLR signaling components during late-phase activation

Science Signaling

Volumn 6, Issue 295, 2013, Pages

  Ma, Jianhui ^a   Bang, Bo Ram ^a   Lu, Jiawei ^a,b   Eun, So Young ^c   Otsuka, Motoyuki ^d   Croft, Michael ^c   Tobias, Peter ^a   Han, Jiahuai ^b   Takeuchi, Osamu ^e   Akira, Shizuo ^f   Karin, Michael ^g   Yagita, Hideo ^h   Kang, Young Jun ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b XIAMEN UNIVERSITY   (China)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f OSAKA UNIVERSITY   (Japan)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CD137 LIGAND; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; LIGAND; LIPOPOLYSACCHARIDE; TOLL INTERLEUKIN 1 RECEPTOR DOMAIN CONTAINING ADAPTOR PROTEIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1 BINDING PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

4-1BB LIGAND; ANIMALS; HEK293 CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LIPOPOLYSACCHARIDES; MAP KINASE KINASE KINASES; MEMBRANE GLYCOPROTEINS; MICE; PROTEIN TRANSPORT; RECEPTORS, INTERLEUKIN-1; SEPSIS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885820620     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2004431     Document Type: Article

References (45)

1. D. M. Underhill, Toll-like receptors and microbes take aim at each other. Curr. Opin. Immunol. 16, 483-487 (2004).
2. S. Akira, S. Uematsu, O. Takeuchi, Pathogen recognition and innate immunity. Cell 124, 783-801 (2006).
3. Y. Bulut, E. Faure, L. Thomas, O. Equils, M. Arditi, Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: Role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 167, 987-994 (2001).
4. G. Zhang, S. Ghosh, Negative regulation of Toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 277, 7059-7065 (2002).
5. P. Gray, A. Dunne, C. Brikos, C. A. Jefferies, S. L. Doyle, L. A. O'Neill, MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction. J. Biol. Chem. 281, 10489-10495 (2006).
6. A. Mansell, R. Smith, S. L. Doyle, P. Gray, J. E. Fenner, P. J. Crack, S. E. Nicholson, D. J. Hilton, L. A. O'Neill, P. J. Hertzog, Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7, 148-155 (2006).
7. A. Dunne, S. Carpenter, C. Brikos, P. Gray, A. Strelow, H. Wesche, N. Morrice, L. A. O'Neill, IRAK1 and IRAK4 promote phosphorylation, ubiquitination, and degradation of MyD88 adaptor-like (Mal). J. Biol. Chem. 285, 18276-18282 (2010).
8. S. Janssens, R. Beyaert, Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11, 293-302 (2003).
9. N. Suzuki, S. Suzuki, G. S. Duncan, D. G. Millar, T. Wada, C. Mirtsos, H. Takada, A. Wakeham, A. Itie, S. Li, J. M. Penninger, H. Wesche, P. S. Ohashi, T. W. Mak, W. C. Yeh, Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416, 750-756 (2002).
10. K. Honda, H. Yanai, T. Mizutani, H. Negishi, N. Shimada, N. Suzuki, Y. Ohba, A. Takaoka, W. C. Yeh, T. Taniguchi, Role of a transductional- transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 101, 15416-15421 (2004).
11. M. Koziczak-Holbro, C. Joyce, A. Glück, B. Kinzel, M. Müller, C. Tschopp, J. C. Mathison, C. N. Davis, H. Gram, IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and toll-like receptor 7-mediated signaling and gene expression. J. Biol. Chem. 282, 13552-13560 (2007).
12. T. W. Kim, K. Staschke, K. Bulek, J. Yao, K. Peters, K. H. Oh, Y. Vandenburg, H. Xiao, W. Qian, T. Hamilton, B. Min, G. Sen, R. Gilmour, X. Li, A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 204, 1025-1036 (2007).
13. P. Kanakaraj, P. H. Schafer, D. E. Cavender, Y. Wu, K. Ngo, P. F. Grealish, S. A. Wadsworth, P. A. Peterson, J. J. Siekierka, C. A. Harris, W. P. Fung-Leung, Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J. Exp. Med. 187, 2073-2079 (1998).
14. J. A. Thomas, J. L. Allen, M. Tsen, T. Dubnicoff, J. Danao, X. C. Liao, Z. Cao, S. A. Wasserman, Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J. Immunol. 163, 978-984 (1999).
15. T. Kawagoe, S. Sato, K. Matsushita, H. Kato, K. Matsui, Y. Kumagai, T. Saitoh, T. Kawai, O. Takeuchi, S. Akira, Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat. Immunol. 9, 684-691 (2008).
16. Y. Choi, Role of TRAF6 in the immune system. Adv. Exp. Med. Biol. 560, 77-82 (2005).
17. H. Wu, J. R. Arron, TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. Bioessays 25, 1096-1105 (2003).
18. A. Dunne, L. A. O'Neill, The interleukin-1 receptor/Toll-like receptor superfamily: Signal transduction during inflammation and host defense. Sci. STKE 2003, re3 (2003).
19. Z. Jiang, T. W. Mak, G. Sen, X. Li, Toll-like receptor 3-mediated activation of NF-κB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-β. Proc. Natl. Acad. Sci. U.S.A. 101, 3533-3538 (2004).
20. T. H. Watts, TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23, 23-68 (2005).
21. M. Croft, The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9, 271-285 (2009).
22. Y. J. Kang, S. O. Kim, S. Shimada, M. Otsuka, A. Seit-Nebi, B. S. Kwon, T. H. Watts, J. Han, Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages. Nat. Immunol. 8, 601-609 (2007).
23. A. D. Watts, N. H. Hunt, Y. Wanigasekara, G. Bloomfield, D. Wallach, B. D. Roufogalis, G. Chaudhri, A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'. EMBO J. 18, 2119-2126 (1999).
24. M. Sun, S. Lee, S. Karray, M. Levi-Strauss, K. T. Ames, P. J. Fink, Cutting edge: Two distinct motifs within the Fas ligand tail regulate Fas ligand-mediated costimulation. J. Immunol. 179, 5639-5643 (2007).
25. K. M. Dennehy, G. D. Brown, The role of the β-glucan receptor Dectin-1 in control of fungal infection. J. Leukoc. Biol. 82, 253-258 (2007).
26. M. Novotney, Z. L. Chang, H. Uchiyama, T. Suzuki, Protein kinase C in tumoricidal activation of mouse macrophage cell lines. Biochemistry 30, 5597-5604 (1991).
27. L. Shapira, S. Takashiba, C. Champagne, S. Amar, T. E. Van Dyke, Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes. J. Immunol. 153, 1818-1824 (1994).
28. S. Onodera, Elevation of intracellular cyclic adenosine 3′,5′-monophosphate levels in macrophages activated with lipopolysaccharide for tumor cell killing. Chem. Pharm. Bull. 39, 991-993 (1991).
29. M. Fujihara, M. Muroi, Y. Muroi, N. Ito, T. Suzuki, Mechanism of lipopolysaccharide-triggered junB activation in a mouse macrophage-like cell line (J774). J. Biol. Chem. 268, 14898-14905 (1993).
30. M. Ojaniemi, V. Glumoff, K. Harju, M. Liljeroos, K. Vuori, M. Hallman, Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur. J. Immunol. 33, 597-605 (2003).
31. M. Muroi, T. Suzuki, Role of protein kinase A in LPS-induced activation of NF-κB proteins of a mouse macrophage-like cell line, J774. Cell. Signal. 5, 289-298 (1993).
32. T. Horng, G. M. Barton, R. Medzhitov, TIRAP: An adapter molecule in the Toll signaling pathway. Nat. Immunol. 2, 835-841 (2001).
33. M. Yamamoto, S. Sato, H. Hemmi, H. Sanjo, S. Uematsu, T. Kaisho, K. Hoshino, O. Takeuchi, M. Kobayashi, T. Fujita, K. Takeda, S. Akira, Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420, 324-329 (2002).
34. J. H. Shim, C. Xiao, A. E. Paschal, S. T. Bailey, P. Rao, M. S. Hayden, K. Y. Lee, C. Bussey, M. Steckel, N. Tanaka, G. Yamada, S. Akira, K. Matsumoto, S. Ghosh, TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19, 2668-2681 (2005).
35. G. Takaesu, R. M. Surabhi, K. J. Park, J. Ninomiya-Tsuji, K. Matsumoto, R. B. Gaynor, TAK1 is critical for IκB kinase-mediated activation of the NF-κB pathway. J. Mol. Biol. 326, 105-115 (2003).
36. A. Kanayama, R. B. Seth, L. Sun, C. K. Ea, M. Hong, A. Shaito, Y. H. Chiu, L. Deng, Z. J. Chen, TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell 15, 535-548 (2004).
37. C. Wang, G. H. Lin, A. J. McPherson, T. H. Watts, Immune regulation by 4-1BB and 4-1BBL: Complexities and challenges. Immunol. Rev. 229, 192-215 (2009).
38. T. Horng, G. M. Barton, R. A. Flavell, R. Medzhitov, The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420, 329-333 (2002).
39. F. J. Sheedy, L. A. O'Neill, The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling. J. Leukoc. Biol. 82, 196-203 (2007).
40. B. Ferwerda, S. Alonso, K. Banahan, M. B. McCall, E. J. Giamarellos-Bourboulis, B. P. Ramakers, M. Mouktaroudi, P. R. Fain, N. Izagirre, D. Syafruddin, T. Cristea, F. P. Mockenhaupt, M. Troye-Blomberg, O. Kumpf, B. Maiga, A. Dolo, O. Doumbo, S. Sundaresan, G. Bedu-Addo, C. R. van, L. Hamann, D. Y. Oh, R. R. Schumann, L. A. Joosten, C. de la Rúa, R. Sauerwein, J. P. Drenth, B. J. Kullberg, A. J. van der Ven, A. V. Hill, P. Pickkers, J. W. van der Meer, L. A. O'Neill, M. G. Netea, Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc. Natl. Acad. Sci. U.S.A. 106, 10272-10277 (2009).
41. Y. J. Kang, J. Chen, M. Otsuka, J. Mols, S. Ren, Y. Wang, J. Han, Macrophage deletion of p38α partially impairs lipopolysaccharide-induced cellular activation. J. Immunol. 180, 5075-5082 (2008).
42. L. C. Hsu, T. Enzler, J. Seita, A. M. Timmer, C. Y. Lee, T. Y. Lai, G. Y. Yu, L. C. Lai, V. Temkin, U. Sinzig, T. Aung, V. Nizet, I. L. Weissman, M. Karin, IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ. Nat. Immunol. 12, 144-150 (2011).
43. S. M. Roberson, W. S. Walker, Immortalization of cloned mouse splenic macrophages with a retrovirus containing the v-raf/mil and v-myc oncogenes. Cell. Immunol. 116, 341-351 (1988).
44. V. Hornung, F. Bauernfeind, A. Halle, E. O. Samstad, H. Kono, K. L. Rock, K. A. Fitzgerald, E. Latz, Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847-856 (2008).
45. T. Futagawa, H. Akiba, T. Kodama, K. Takeda, Y. Hosoda, H. Yagita, K. Okumura, Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int. Immunol. 14, 275-286 (2002).